Psychiatry and Neurology, Neurology · Oklahoma City, OK
NPI
1770521064
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4221 S Western Ave, 5000
Oklahoma City, OK, 73109
Phone (405) 644-5165
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
777 services
Medicare patients, 2024
394
Average age 72
Drug cost, 2024
$4.8M
676 prescriptions
Company payments, 2025
$17.5
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua C Kershen was code 99215 (office e&m - established), 252 times for 149 patients. In total Joshua C Kershen billed 777 services in 22 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 252 | 149 | $110.19 | $28K |
| 95886 Electrical Nerve Conductivity | Office | 142 | 128 | $54.76 | $7,776 |
| 99205 Office E&M - New | Office | 72 | 72 | $129.34 | $9,313 |
| 99223 Hospital E&M - Initial | Facility | 54 | 54 | $116.78 | $6,306 |
| 95910 Electrical Nerve Conductivity | Office | 46 | 46 | $107.15 | $4,929 |
| 95909 Electrical Nerve Conductivity | Office | 38 | 37 | $83.34 | $3,167 |
| 99233 Hospital E&M - Subsequent | Facility | 38 | 30 | $78.36 | $2,978 |
| 95911 Electrical Nerve Conductivity | Office | 33 | 33 | $139.65 | $4,608 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 21 | 19 | $11.18 | $235 |
| G0425 Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 21 | 21 | $68.83 | $1,445 |
| 99214 Office E&M - Established | Office | 17 | 15 | $63.97 | $1,088 |
By year: 2022 $93K for 872 services; 2023 $85K for 784 services; 2024 $73K for 777 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua C Kershen prescribed most often to Medicare patients was Prednisone, with 93 prescriptions and refills. In total Joshua C Kershen wrote 676 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 93 | 273 | 33 | $1,076 |
| Radicava Ors Edaravone | 75 | 75 | Under 11 | $1.1M |
| Carbidopa-Levodopa Carbidopa/Levodopa | 70 | 190 | 23 | $1,872 |
| Gabapentin Generic | 41 | 106 | 17 | $1,654 |
| Pyridostigmine Bromide Generic | 37 | 78 | 12 | $2,929 |
| Mycophenolate Mofetil Generic | 36 | 71 | Under 11 | $5,252 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 34 | 34 | Under 11 | $359K |
| Riluzole Generic | 31 | 62 | Under 11 | $7,192 |
| Azathioprine Generic | 23 | 61 | Under 11 | $2,504 |
| Omeprazole Generic | 22 | 64 | Under 11 | $484 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 22 | 22 | Under 11 | $163K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 20 | 60 | Under 11 | $550 |
| Evrysdi Risdiplam | 18 | 18 | Under 11 | $476K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 17 | 17 | Under 11 | $49.42 |
| Skyclarys Omaveloxolone | 13 | 13 | Under 11 | $419K |
Brand drugs: 216 claims; generic drugs: 460 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua C Kershen $17.5 ($17.5 in general payments such as food, travel and fees) from 1 company. The largest payer was ITF Therapeutics LLC with $17.5.
| Company | Payments | Amount |
|---|---|---|
| ITF Therapeutics LLC | 1 | $17.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.